Empagliflozin mitigates cardiac hypertrophy through cardiac RSK/NHE-1 inhibition
Article in Biomedicine & Pharmacotherapy (March 2024)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Article in Biomedicine & Pharmacotherapy (March 2024)
Article in Microbial Cell (January 2024)
Book chapter (January 2024)